ATE227341T1 - Trimerisierende polypeptide, deren herstellung und verwendung - Google Patents
Trimerisierende polypeptide, deren herstellung und verwendungInfo
- Publication number
- ATE227341T1 ATE227341T1 AT95918689T AT95918689T ATE227341T1 AT E227341 T1 ATE227341 T1 AT E227341T1 AT 95918689 T AT95918689 T AT 95918689T AT 95918689 T AT95918689 T AT 95918689T AT E227341 T1 ATE227341 T1 AT E227341T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptides
- amino acid
- amino acids
- preparation
- heterotrimerization
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 229920001184 polypeptide Polymers 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 150000001413 amino acids Chemical class 0.000 abstract 4
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- 102000004405 Collectins Human genes 0.000 abstract 1
- 108090000909 Collectins Proteins 0.000 abstract 1
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000010899 nucleation Methods 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 229920001542 oligosaccharide Polymers 0.000 abstract 1
- 150000002482 oligosaccharides Chemical class 0.000 abstract 1
- 108020001580 protein domains Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4726—Lectins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/785—Alveolar surfactant peptides; Pulmonary surfactant peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9409768A GB9409768D0 (en) | 1994-05-16 | 1994-05-16 | Trimerising polypeptides |
| PCT/GB1995/001104 WO1995031540A1 (en) | 1994-05-16 | 1995-05-16 | Trimerising polypeptides, their manufacture and use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE227341T1 true ATE227341T1 (de) | 2002-11-15 |
Family
ID=10755201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95918689T ATE227341T1 (de) | 1994-05-16 | 1995-05-16 | Trimerisierende polypeptide, deren herstellung und verwendung |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6190886B1 (de) |
| EP (1) | EP0757720B1 (de) |
| JP (2) | JPH10500298A (de) |
| AT (1) | ATE227341T1 (de) |
| AU (1) | AU2451995A (de) |
| CA (1) | CA2190264A1 (de) |
| DE (1) | DE69528761T2 (de) |
| DK (1) | DK0757720T3 (de) |
| ES (1) | ES2186718T3 (de) |
| GB (1) | GB9409768D0 (de) |
| PT (1) | PT757720E (de) |
| WO (1) | WO1995031540A1 (de) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO591797A0 (en) | 1997-03-27 | 1997-04-24 | Commonwealth Scientific And Industrial Research Organisation | High avidity polyvalent and polyspecific reagents |
| DE69738670D1 (de) * | 1996-10-28 | 2008-06-19 | Inst Suisse De Rech S Experime | Verfahren zur oligomerisation von peptiden |
| WO1998018918A1 (en) * | 1996-10-29 | 1998-05-07 | Commonwealth Scientific And Industrial Research Organisation | Stable expression of triple helical proteins |
| ATE282092T1 (de) | 1997-06-11 | 2004-11-15 | Borean Pharma As | Trimerisierendes modul |
| US7914814B2 (en) * | 1997-09-17 | 2011-03-29 | Strategic Science & Technologies, Llc | Topical delivery of arginine of cause beneficial effects |
| WO1999027964A1 (en) * | 1997-12-01 | 1999-06-10 | Cfy Biomedicals, Inc. | Multivalent recombinant antibodies for treating hrv infections |
| US20030035798A1 (en) * | 2000-08-16 | 2003-02-20 | Fang Fang | Humanized antibodies |
| US7300774B1 (en) * | 1999-12-09 | 2007-11-27 | The Regents Of The University Of California | Multimeric fusion proteins of the TNF superfamily ligands |
| JP2003502024A (ja) * | 1999-05-14 | 2003-01-21 | メディカル リサーチ カウンシル | タンパク質骨格および単量体ポリペプチドを多量体化するためのその使用 |
| AU2002213843B2 (en) | 2000-11-10 | 2008-02-07 | F. Hoffmann-La Roche Ltd. | Apolipoprotein analogues |
| CA2440235A1 (en) * | 2001-03-06 | 2002-09-12 | Mustapha Abdelouahed | Carrier chimeric proteins, targeted carrier chimeric proteins and preparation thereof |
| CA2454358A1 (en) | 2001-07-19 | 2003-07-31 | Perlan Therapeutics, Inc. | Multimeric proteins and methods of making and using same |
| DK1440083T3 (da) | 2001-10-25 | 2013-03-25 | Medical Res Council | Molekyler |
| AU2002359780B2 (en) * | 2001-12-21 | 2009-08-13 | Immunex Corporation | Recombinant polypeptides |
| US20070010658A1 (en) | 2002-10-29 | 2007-01-11 | Holtet Thor L | Trimeric binding proteins for trimeric cytokines |
| US20080166798A1 (en) * | 2003-08-22 | 2008-07-10 | Barnes-Jewish Hospital | Trimerizing Polypeptides and Their Uses |
| US7268116B2 (en) * | 2003-10-02 | 2007-09-11 | Genhunter Corp. | Methods and compositions for producing secreted trimeric receptor analogs and biologically active fusion proteins |
| US8030448B2 (en) | 2004-02-16 | 2011-10-04 | Techno Network Shikoku Co., Ltd. | Polypeptide having collagen-like structure |
| NZ555353A (en) | 2004-11-22 | 2009-12-24 | Anaphore Inc | TNF antagonists |
| EP1960525B1 (de) * | 2005-09-09 | 2013-04-24 | Zymogenetics, Inc. | Verfahren zur herstellung trimerer proteine |
| US10183986B2 (en) | 2005-12-15 | 2019-01-22 | Industrial Technology Research Institute | Trimeric collagen scaffold antibodies |
| US20070264687A1 (en) * | 2005-12-15 | 2007-11-15 | Min-Yuan Chou | Recombinant triplex scaffold-based polypeptides |
| EP2674440B1 (de) | 2005-12-16 | 2019-07-03 | IBC Pharmaceuticals, Inc. | Polyvalente bioaktive anordnungen auf immunglobulinbasis |
| CN103159857B (zh) * | 2007-05-21 | 2014-11-05 | 财团法人工业技术研究院 | 以重组的三股螺旋支架为基础的复合物 |
| CA2692802C (en) * | 2007-07-10 | 2017-05-30 | Oliver Hill | Tnf superfamily collectin fusion proteins |
| CA2704207A1 (en) | 2007-10-29 | 2009-05-07 | Virginia Tech Intellectual Properties, Inc. | Porcine dc-sign, icam-3 and lsectin and uses thereof |
| EP2294202B1 (de) | 2008-07-08 | 2015-05-20 | Medicago Inc. | Lösliche rekombinante influenza-antigene |
| EP2379585A2 (de) | 2008-10-10 | 2011-10-26 | Anaphore, Inc. | Trail-r1 und trail-r2 bindende polypeptide |
| DK2380979T3 (da) * | 2008-12-22 | 2015-06-22 | Univ Hokkaido Nat Univ Corp | Proteinstof med trippelhelixstruktur samt fremgangsmåde til dets fremstilling |
| JP5844158B2 (ja) * | 2009-01-09 | 2016-01-13 | アポゲニクス ゲゼルシャフト ミット ベシュレンクテル ハフツングApogenix GmbH | 三量体形成融合タンパク質 |
| WO2010122181A1 (es) * | 2009-04-20 | 2010-10-28 | Universidad Autónoma de Madrid | Proteínas oligoméricas y sus aplicaciones |
| US20110086806A1 (en) * | 2009-10-09 | 2011-04-14 | Anaphore, Inc. | Polypeptides that Bind IL-23R |
| US20110086770A1 (en) * | 2009-10-09 | 2011-04-14 | Anaphore, Inc. | Combinatorial Libraries Based on C-type Lectin-like Domain |
| DK2970427T3 (da) | 2013-03-15 | 2020-03-09 | Geoffrey W Stone | Sammensætning bestående af antigen bundet til en tnf-superfamilieligand |
| JP2014218510A (ja) * | 2014-08-11 | 2014-11-20 | アポゲニクスゲゼルシャフト ミット ベシュレンクテルハフツングApogenix GmbH | 三量体形成融合タンパク質 |
| EP3374378B1 (de) | 2015-11-13 | 2021-02-17 | Spiber Technologies AB | Ladungsumgekehrte n-terminale spinnenseidenproteindomäne und verwendungen davon |
| GB201522610D0 (en) * | 2015-12-22 | 2016-02-03 | Univ Southampton | Protein |
| JP2016210791A (ja) * | 2016-08-03 | 2016-12-15 | アポゲニクス アーゲー | 三量体形成融合タンパク質 |
| US11377490B2 (en) | 2017-05-31 | 2022-07-05 | Sichuan Clover Biopharmaceuticals, Inc | Method for treating cancer using disulfide-linked trimeric 4-1BBL |
| WO2021249011A1 (en) | 2020-06-10 | 2021-12-16 | Sichuan Clover Biopharmaceuticals, Inc. | Hiv vaccine compositions, methods, and uses thereof |
| WO2021249116A1 (en) | 2020-06-10 | 2021-12-16 | Sichuan Clover Biopharmaceuticals, Inc. | Coronavirus vaccine compositions, methods, and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5716805A (en) * | 1991-10-25 | 1998-02-10 | Immunex Corporation | Methods of preparing soluble, oligomeric proteins |
-
1994
- 1994-05-16 GB GB9409768A patent/GB9409768D0/en active Pending
-
1995
- 1995-05-16 WO PCT/GB1995/001104 patent/WO1995031540A1/en not_active Ceased
- 1995-05-16 ES ES95918689T patent/ES2186718T3/es not_active Expired - Lifetime
- 1995-05-16 AT AT95918689T patent/ATE227341T1/de not_active IP Right Cessation
- 1995-05-16 AU AU24519/95A patent/AU2451995A/en not_active Abandoned
- 1995-05-16 US US08/737,629 patent/US6190886B1/en not_active Expired - Lifetime
- 1995-05-16 JP JP7529462A patent/JPH10500298A/ja not_active Withdrawn
- 1995-05-16 EP EP95918689A patent/EP0757720B1/de not_active Expired - Lifetime
- 1995-05-16 PT PT95918689T patent/PT757720E/pt unknown
- 1995-05-16 DK DK95918689T patent/DK0757720T3/da active
- 1995-05-16 CA CA002190264A patent/CA2190264A1/en not_active Abandoned
- 1995-05-16 DE DE69528761T patent/DE69528761T2/de not_active Expired - Lifetime
-
2005
- 2005-08-09 JP JP2005230930A patent/JP3836865B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1995031540A1 (en) | 1995-11-23 |
| DK0757720T3 (da) | 2003-03-17 |
| DE69528761D1 (de) | 2002-12-12 |
| JPH10500298A (ja) | 1998-01-13 |
| PT757720E (pt) | 2003-03-31 |
| ES2186718T3 (es) | 2003-05-16 |
| EP0757720A1 (de) | 1997-02-12 |
| CA2190264A1 (en) | 1995-11-23 |
| AU2451995A (en) | 1995-12-05 |
| GB9409768D0 (en) | 1994-07-06 |
| EP0757720B1 (de) | 2002-11-06 |
| JP2005328851A (ja) | 2005-12-02 |
| DE69528761T2 (de) | 2003-07-17 |
| JP3836865B2 (ja) | 2006-10-25 |
| US6190886B1 (en) | 2001-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE227341T1 (de) | Trimerisierende polypeptide, deren herstellung und verwendung | |
| Glanville et al. | Isolation and Characterization of a Native Placental Basement‐Membrane Collagen and Its Component α Chains | |
| ATE277078T1 (de) | N-terminal modifizierte polypeptide, und herstellungsprozess | |
| DE69432109D1 (de) | Synthetische, vielfache tandemwiederholungen des mucinpeptides und seiner derivate und deren verwendung | |
| ATE513042T1 (de) | Tumorassoziierte antigenderivate der mage-familie,nukleinsäuresequenzen, die dafür kodieren, zur herstellung von fusionsproteinen und zusammensetzungen zur impfung | |
| BR9510202B1 (pt) | composiÇço de carboidrato polidispersa, processo aplicado a uma soluÇço de composiÇço de carboidrato polidispersa, processo de preparaÇço de uma composiÇço, composiÇço tendo uma estrutura cremosa, composiÇço peletizada e composiÇço cosmÉtica, alimentÍcia e/ou de alimento. | |
| ATE221573T1 (de) | Neue amyloid-precursor-proteine und verfahren zur deren verwendung | |
| DE68919246D1 (de) | Verfahren zur Herstellung von Aminosäuren. | |
| FI20075338A7 (fi) | gp350/220:n ei silmukoivia muutoksia | |
| CY1109518T1 (el) | Αναστολεας ενεργοποιητη αυξητικου παραγοντα ηπατοκυτταρων για χρηση σε διαμορφωση αγγειογενεσης και καρδιοαγγειωσης | |
| ATE375090T1 (de) | Bioaktive peptide, ihre verwendung und verfahren zu ihre herstellung | |
| CA2267210C (en) | Method of stabilizing useful protein and useful protein composition | |
| ATE166881T1 (de) | Verfahren zur herstellung von faktor viii | |
| WO1991011462A3 (en) | Merosin, nucleic acids encoding, fragments and uses thereof | |
| ATE118982T1 (de) | Verfahren zur herstellung von transparenten milchmolkeproteinen und milchmolkeproteinprodukte. | |
| SE8801723D0 (sv) | Fibronectin binding protein as well as its preparation | |
| WO1995008628A3 (en) | Nucleic acids encoding merosin, merosin fragments and uses thereof | |
| ES2307515T3 (es) | Activacion o inhibicion de la angiogenesis y la cardiovascularizacion. | |
| DE68905097D1 (de) | Peptid-molekuele, wirksam gegen gram-positive keime. | |
| ATE224403T1 (de) | Verwendung von kaseinfragmenten als wachstumerförderer | |
| DE58909261D1 (de) | Ancrod-proteine, ihre herstellung und verwendung. | |
| BR0012740A (pt) | Compostos para tratamento de distúrbios do sistema infeccioso e imune e métodos para seu emprego | |
| ATE130872T1 (de) | Ancrod ähnliche proteine, ihre herstellung und verwendung. | |
| EP0446361A4 (en) | Polypeptide, production thereof, and pharmaceutical composition and cosmetic containing said polypeptide | |
| WO1999042586A3 (en) | Exo1 and exo2, exocytotic proteins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0757720 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |